BioMarin Pharmaceutical Inc. Falling On The Genzyme News
November 13, 2009 11:57 AM
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) is falling some 4% on news that some Genzyme drugs could be contaminated.
BioMarin Pharma has three approved products and multiple investigational product candidates.


























